Advantages of PRF (Platelet-Rich Fibrin) over PRP (Platelet-Rich Plasma)
Release time:
2019-07-18
Overview:
PRF (Platelet-Rich Fibrin)
PRF, or platelet-rich fibrin, is an abbreviation for platelet-rich fibrin. Discovered in 2001 by French scientists including Choukroun et al., it represents the second-generation platelet concentrate following platelet-rich plasma. PRF is defined as an autologous biomaterial composed of leukocytes and platelet-rich fibrin.
Chinese name: Platelet-Rich Fibrin; Foreign name: Platelet-rich fibrin; Abbreviation: PRF
Preparation method
1. Draw 10 ml of blood via venipuncture and place it into a sterile tube without anticoagulant.
2. Immediately centrifuge the test tube at 3000 r/min for 10 minutes.
3. After standing still, the blood sample can be divided into three layers. Between the red cell debris at the bottom layer and the pale yellow, clear platelet-rich plasma at the top layer, the pale yellow gel in the middle layer is carefully removed—this is known as platelet-rich fibrin.
4. Discard the supernatant and remove the red blood cell fraction from the bottom of the gel-like material to obtain a primary PRF gel. Then, allow it to stand undisturbed in a dry, sterilized container for 10 minutes, enabling it to naturally contract and release its contained serum. Alternatively, absorb the serum using sterile gauze while gently squeezing and shaping the gel to produce a platelet-rich fibrin membrane with a specific shape, elasticity, and toughness.
PRF applications
Currently, PRF has been widely applied in departments such as dentistry, maxillofacial surgery, orthopedics, and plastic surgery. In the past, it was primarily prepared in film form for wound repair. Recently, some researchers have explored mixing the prepared PRF gel with autologous fat particles at a specific ratio and using this mixture in autologous fat grafting procedures, such as breast augmentation with autologous fat, thereby improving the survival rate of the grafted fat.
Advantages over PRP (Platelet-Rich Plasma)
1. Compared to PRP, the preparation of PRF does not involve any exogenous additives, thereby avoiding the risks of immune rejection, cross-infection, and coagulation dysfunction. Moreover, its preparation technique is simplified—requiring only a single-step centrifugation. After drawing blood into a centrifuge tube, the tube is promptly subjected to low-speed centrifugation. The silicon elements present in the glass centrifuge tubes promote platelet activation and physiological fibrin polymerization, initiating a simulation of the natural coagulation process and allowing for the collection of a natural clot.
2. From the perspective of ultrastructure, it was found that the distinct conformation of the fibrin network is the primary structural feature differentiating the two materials; they exhibit significant differences in both density and type. The density of fibrin is determined by the amount of its precursor, fibrinogen, while its type depends on the total amount of thrombin and the rate of polymerization. In the conventional PRP preparation process, unpolymerized fibrinogen dissolves into the platelet-poor plasma (PPP) and is directly discarded. Consequently, when thrombin is added in the third step to induce clotting, the fibrinogen content has already been substantially reduced, resulting in a fibrin network with a density far lower than that of a physiological blood clot. Moreover, due to the presence of exogenous additives, the high concentration of thrombin significantly accelerates the polymerization of fibrinogen, leading to the formation of a fibrin network composed of four molecules of fibrinogen per unit. Such a network is rigid and lacks elasticity, which hinders its ability to effectively trap cytokines and promote cell migration. Therefore, the maturity of the fibrin network formed by PRF is superior to that of PRP and more closely resembles the natural physiological state.
3. The cytokine-release patterns of PRF differ from those of conventional PRP products. Due to the inclusion of exogenous additives, PRP products instantly activate platelets within the PRP, and the cytokines released after activation also include cytokines that further accelerate platelet activation. As a result, the release of cytokines peaks around the time when exogenous additives are added—typically in the early stages of the healing process—and declines significantly in later stages, leading to an uneven and less sustained release profile. In contrast, thanks to the structural advantages of PRF, cytokines can be released relatively persistently, thereby maximizing fulfillment of clinical needs.
4. Although PRF and certain leukocyte-rich PRP products can provide certain immune and anti-infective functions, offering numerous advantages for tissue regeneration and wound healing, a comparison of their structures and properties reveals that PRF’s proximity to physiological conditions enables it to better harness the biological potential of platelet concentrates in promoting tissue regeneration.
Previous: